This news out of Thailand is huge for two reasons.
#1 it expands the size of the international cannabis market. Thailand is one of the largest countries in Asia. Its population of 70 million citizens is the 10th largest out of 50 in Asia according to Wikipedia. Thailand’s GDP of $450 million in 2017 made it the 8th largest economy in the region and the 26th largest in the world.
#2 as you read above Asia is home to some of the strictest drug laws in the world. This demonstrates that as attitudes about cannabis change all around the world, they are also changing in Asia. The Asian population is massive – its the most populous continent in the world. Progress on cannabis opens up huge new markets.
Members, please log in to CST to read how this news is going to impact our model portfolio and why this is massive for the global cannabis industry.
The Agriculture Improvement Act of 2018 (the 2018 Farm Bill) has officially been signed into law. One of the major components of this legislation of industrial hemp. This blog post will mainly focus on what the tax implications of this legalization and contrast tax differences of a federal legal hemp business versus a federally illegal business subject to section 280E. Continue reading “The 2018 Farm Bill – What it Means for Hemp Farmers’ Tax Bill”→
Defending a 2017 law that set regulations for the state’s medical-marijuana industry, Florida Department of Health attorneys have asked an appeals court to overturn a circuit judge’s ruling that they say “injected confusion and uncertainty” into the licensing of marijuana firms.
The rollout of statewide medical and recreational marijuana programs typically is a grindingly slow process that can take years. Not so in Oklahoma, which moved with lightning speed once voters approved medical cannabis in June.
Starting Jan. 1, Colorado will reap more tax revenue from wholesale deals involving marijuana intended to be sold to consumers after the average prices of those wholesale products rose in the latter part of 2018.
Tilray has signed a global partnership with a division of Swiss drug giant Novartis to develop and distribute its medical marijuana in legal jurisdictions around the world.
The Canadian pot firm said Tuesday it’s reached an agreement with Sandoz to boost the availability of medical cannabis products globally, building on an existing alliance with Sandoz Canada. The two companies will work together to commercialize Tilray’s non-smokable medical marijuana offerings, co-brand certain products, develop new products and educate pharmacists and physicians about pot. Continue reading “Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal”→
Iowa is now home to five medical marijuana dispensaries. They were approved under a law passed last March, permitting the sale of specific cannabis-derived products to those suffering from qualifying conditions including untreatable pain, side effects of cancer, seizures, ALS, and others. Continue reading “Medical Cannabis Dispensaries Have Arrived In Iowa”→